Immuneering Corporation (NASDAQ: IMRX)
$1.15
-0.1050 ( -8.40% ) 112.2K
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Market Data
Open
$1.15
Previous close
$1.25
Volume
112.2K
Market cap
$34.69M
Day range
$1.14 - $1.25
52 week range
$1.05 - $11.06
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 21, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 19, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
8-k | 8K-related | 14 | Mar 14, 2024 |
4 | Insider transactions | 1 | Mar 12, 2024 |
3 | Insider transactions | 2 | Mar 12, 2024 |